Currently, there are 131.90M common shares owned by the public and among those 131.46M shares have been available to trade.
The company’s stock has a 5-day price change of 2.79% and 21.48% over the past three months. CMA shares are trading 2.85% year to date (YTD), with the 12-month market performance up to 22.83% higher. It has a 12-month low price of $37.40 and touched a high of $58.50 over the same period. CMA has an average intraday trading volume of 2.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.20%, 6.47%, and 10.26% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Comerica, Inc. (NYSE: CMA) shares accounts for 83.09% of the company’s 131.90M shares outstanding.
It has a market capitalization of $7.62B and a beta (3y monthly) value of 1.24. The stock’s trailing 12-month PE ratio is 12.70, while the earnings-per-share (ttm) stands at $4.52. The company has a debt-to-equity ratio at 1.36. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.87% over the week and 2.53% over the month.
Earnings per share for the fiscal year are expected to decrease by -24.88%, and 9.62% over the next financial year. EPS should shrink at an annualized rate of -10.70% over the next five years, compared to -2.20% over the past 5-year period.
Looking at the support for the CMA, a number of firms have released research notes about the stock. Keefe Bruyette stated their Outperform rating for the stock in a research note on September 05, 2024, with the firm’s price target at $69. Truist coverage for the Comerica, Inc. (CMA) stock in a research note released on July 22, 2024 offered a Hold rating with a price target of $53. Raymond James was of a view on July 02, 2024 that the stock is Outperform, while Citigroup gave the stock Neutral rating on May 06, 2024, issuing a price target of $56. Deutsche Bank on their part issued Hold rating on April 10, 2024.
